Odyssey Health Extends Maturity Dates on Multiple Convertible Promissory Notes

summarizeSummary

Odyssey Health, Inc. extended the maturity dates for multiple convertible promissory notes, including those with directors, officers, and significant investors, indicating ongoing financial management challenges.

check_boxKey Events

• Maturity Dates Extended for Insider-Held Notes

  The company entered into four Amendment No. 12 agreements to convertible promissory notes with two directors and two officers, extending their maturity dates to January 31, 2027.

• Significant Investor Note Extended

  Amendment No. 11 was executed for a $1.05 million convertible promissory note with LGH Investments, LLC, extending its maturity to April 30, 2026. This note represents a substantial portion of the company's market capitalization.

• Additional Investor Notes Extended

  The maturity dates for convertible promissory notes with accredited investors Jonathan Lutz and Peter J. D'Arruda were also extended to January 31, 2027. The note with Peter J. D'Arruda was for $300,000.

auto_awesomeAnalysis

Odyssey Health, a micro-cap company, has extended the maturity dates on several significant convertible promissory notes, including those held by directors, officers, and accredited investors. While these extensions prevent immediate default and provide the company with additional time to address its financial obligations, they also highlight ongoing liquidity challenges and the company's reliance on existing lenders, including insiders. The extension of the $1.05 million note with LGH Investments, LLC, which represents a substantial portion of the company's market capitalization, is particularly notable. Investors should monitor future filings for signs of improved financial health or further debt restructuring.